Bull Hedging
  • Politics
  • Stocks
  • Business
  • Investing
  • Politics
  • Stocks
  • Business
  • Investing

Bull Hedging

Politics

Trump amends executive order raising China tariffs to 20% over ‘failure to address’ fentanyl crisis

by admin March 4, 2025
March 4, 2025
Trump amends executive order raising China tariffs to 20% over ‘failure to address’ fentanyl crisis

The White House announced Monday that China will face increased tariffs, citing the ongoing fentanyl crisis in the U.S. as the main reason for the decision.

In a post on X, the Rapid Response 47 account shared the text of an executive order (EO) signed by President Donald Trump on Monday. The Chinese government will now face 20% tariffs ‘over their failure to address the fentanyl pouring into our country,’ the EO stated.

The tariffs against China, which were originally only 10%, will go into effect on Tuesday. In Monday’s order, Trump said that the Chinese government has failed ‘to blunt the sustained influx of synthetic opioids, including fentanyl, flowing from [their country],’ and that such failure constitutes an ‘unusual and extraordinary threat.’

Trump also said that the crisis jeopardizes the ‘national security, foreign policy, and economy of the United States.’

‘I have determined that the [People’s Republic of China] has not taken adequate steps to alleviate the illicit drug crisis through cooperative enforcement actions, and that the crisis described in Executive Order 14195 has not abated,’ the order read. 

‘In recognition of the fact that the PRC has not taken adequate steps to alleviate the illicit drug crisis, section 2(a) of Executive Order 14195 is hereby amended by striking the words ‘10 percent’ and inserting in lieu thereof the words ‘20 percent’.’

The Trump administration is already imposing 25% tariffs on Canadian and Mexican goods, which were announced last month and will also go into effect on Tuesday. On Monday, Peter Navarro, the White House senior counselor on trade and manufacturing, defended the tariffs to CNBC and argued that the issue ‘starts in communist China with the precursor chemicals.’

‘It comes into Mexico, and they make the fentanyl. But they also have these pill presses. So they do the counterfeits,’ Navarro explained. ‘And they’re using Canada as a transit hub and secondary point to manufacture as well. So this is a Canada-Mexico-China thing.’

The Chinese government has opposed the tariffs since they were announced. In a Feb. 1 statement, China’s Ministry of Foreign Affairs claimed that China is ‘one of the world’s toughest countries on counternarcotics both in terms of policy and its implementation.’

‘Additional tariffs are not constructive and bound to affect and harm the counternarcotics cooperation between the two sides in the future,’ the statement read. ‘China calls on the U.S. to correct its wrongdoings, maintain the hard-won positive dynamics in the counternarcotics cooperation, and promote the steady, sound and sustainable development of China-U.S. relationship.’

Fox News Digital’s Anders Hagstrom contributed to this report.

This post appeared first on FOX NEWS

previous post
Theme of Trump’s address to Congress revealed
next post
‘AmerExit’? Republicans push for US to leave NATO amid stalled Ukraine peace negotiations

Related Posts

Republican populism craters as Trump stumbles, Democrats surge

December 6, 2025

GOP outperformed Dems on voter registration in key...

May 22, 2025

Rubio reveals obscure Biden administration office kept ‘disinformation’...

May 1, 2025

JFK’s daughter says cousin RFK Jr is a...

January 29, 2025

Tesla robots visit Capitol Hill amid anti-DOGE protests,...

March 27, 2025

Trump distances himself from Russia–Ukraine conflict: ‘Not our...

May 22, 2025

Mark Zuckerberg on the stand: ‘Crazy,’ ‘scary’ ideas...

April 16, 2025

REBECCA GRANT: America has a drone problem, and...

December 15, 2024

Kamala Harris back in national spotlight as James...

August 4, 2025

Trump says he is open to extending trade...

June 12, 2025

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio
  • Republican populism craters as Trump stumbles, Democrats surge
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

Recent Comments

No comments to show.

About Us

About Us

Design Magazine

Welcome to Design Magazine. Follow us for daily & updated design tips, guide and knowledge.

Stay Connect

Facebook Twitter Instagram Pinterest Youtube Email

Recent Posts

  • The Real Drivers of This Market: AI, Semis & Robotics

    December 6, 2025
  • S&P 500 Breaking Out Again: What This Means for Your Portfolio

    December 6, 2025
  • Republican populism craters as Trump stumbles, Democrats surge

    December 6, 2025
  • Trump admin warned to take front seat as UN chief race shifts left, boosting anti-US contenders

    December 6, 2025
  • GOP unveils plan for ‘Trump Health Freedom Accounts’ to replace Obamacare subsidies with state waivers

    December 6, 2025
  • Abortion restrictions create major roadblock for bipartisan Obamacare subsidy deal in Senate

    December 6, 2025

Editors’ Picks

  • 1

    Small Caps are Set to Skyrocket in 2025—Here’s What You Need to Know

    December 12, 2024
  • 2

    Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

    September 19, 2025
  • 3

    Ad revenue should stabilize for media companies in 2025 — if they have sports

    December 31, 2024
  • 4

    Trump leaves China guessing what his next move is with unusual inauguration invitation

    December 15, 2024
  • 5

    Zinc Stocks: 4 Biggest Canadian Companies in 2025

    January 15, 2025
  • 6

    Lead Price Forecast: Top Trends for Lead in 2025

    January 11, 2025
  • 7

    Uranium Price Forecast: Top Trends That Will Affect Uranium in 2025

    December 19, 2024
Promotion Image

banner

Categories

  • Business (602)
  • Investing (2,582)
  • Politics (3,117)
  • Stocks (946)
  • About us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Disclaimer: bullhedging.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


Copyright © 2025 bullhedging.com | All Rights Reserved